Format

Send to

Choose Destination
Exp Diabetes Res. 2008;2008:635158. doi: 10.1155/2008/635158.

Intracellular signalling by C-peptide.

Author information

1
Department of Infection, Immunity and Inflammation, University of Leicester, Leicester School of Medicine, P.O. Box 138, Leicester LE1 7RH, England, UK.

Abstract

C-peptide, a cleavage product of the proinsulin molecule, has long been regarded as biologically inert, serving merely as a surrogate marker for insulin release. Recent findings demonstrate both a physiological and protective role of C-peptide when administered to individuals with type I diabetes. Data indicate that C-peptide appears to bind in nanomolar concentrations to a cell surface receptor which is most likely to be G-protein coupled. Binding of C-peptide initiates multiple cellular effects, evoking a rise in intracellular calcium, increased PI-3-kinase activity, stimulation of the Na(+)/K(+) ATPase, increased eNOS transcription, and activation of the MAPK signalling pathway. These cell signalling effects have been studied in multiple cell types from multiple tissues. Overall these observations raise the possibility that C-peptide may serve as a potential therapeutic agent for the treatment or prevention of long-term complications associated with diabetes.

PMID:
18382618
PMCID:
PMC2276616
DOI:
10.1155/2008/635158
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Publishing Corporation Icon for PubMed Central
Loading ...
Support Center